Physician
Family Medicine
Mark Bibler works in the field of Family Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Mark Bibler accepts all Medicare patients.
Schools
University Of Puerto Rico amp Autonomous University Of Guadalajara
University Of Southern California Los Angeles County Hospital
Glendale Adventist Hospital
Procedures Preformed
- Abscess Incision and Drainage
- Biopsy
- Breast Exam
- Colposcopy
- View All
Conditions Treated
- Allergies
- Anxiety
- Arthritis
- Asthma
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Power Select HMO
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- GEHA
- Blue & Gold HMO
- Employer Group HMO
- SmartCare HMO
- WholeCare Network HMO
- MedHealthInsurance
- Medicare MCR
- Molina
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Blue Choice
- Gold Value
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Southern California - LAC+USC Medical Center
-
Universidad Autonoma de Guadalajara
Drug Facts
NPI NUMBER |
|
1427048487 |
NPPES Provider LastName |
|
BIBLER |
NPPES Provider FirstName |
|
MARK |
NPPES Provider ZIPCode |
|
920845566 |
NPPES Provider State |
|
CA |
Specialty Description |
|
Family Practice |
Total Claim Count |
|
2815.0 |
Distinct Opioid Count |
|
5.0 |
Opioid Claim Count |
|
241.0 |
Percent Opioid Claims |
|
8.56 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1427048487 |
Last Name Of The Provider |
BIBLER |
First Name Of The Provider |
MARK |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog